Literature DB >> 23139341

Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners.

Mike D Van Manen1, James Nace, Michael A Mont.   

Abstract

Osteoarthritis (OA) of the knee, one of the most common causes of disability, continues to increase in prevalence as the older adult and obese populations grow. Often, the general practitioner is the first to evaluate a patient with a painful knee that has arthritis. Evidence-based evaluation and treatment guidelines recommend the use of nonoperative treatments before surgical treatment options such as total knee arthroplasty (TKA) are considered. Understanding available nonoperative treatment options is critical for physicians who first encounter patients with OA of the knee. The authors provide an overview of nonoperative treatment options for patients with OA, including weight loss, aerobic exercise, osteopathic manipulative treatment, nonsteroidal anti-inflammatory drugs, and corticosteroid injections. The authors also discuss operative treatment options to be considered before TKA and review indications for TKA when other treatment options have been exhausted.

Entities:  

Mesh:

Year:  2012        PMID: 23139341

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  50 in total

Review 1.  Real-world evidence in rheumatic diseases: relevance and lessons learnt.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-02-06       Impact factor: 2.631

2.  Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model.

Authors:  James McMasters; Scott Poh; Jenny B Lin; Alyssa Panitch
Journal:  J Control Release       Date:  2017-05-08       Impact factor: 9.776

3.  Controlled release of anti-inflammatory peptides from reducible thermosensitive nanoparticles suppresses cartilage inflammation.

Authors:  Jenny B Lin; Scott Poh; Alyssa Panitch
Journal:  Nanomedicine       Date:  2016-05-27       Impact factor: 5.307

Review 4.  Cryotherapy on postoperative rehabilitation of joint arthroplasty.

Authors:  Sheng-Hui Ni; Wen-Tong Jiang; Lei Guo; Yu-Heng Jin; Tian-Long Jiang; Yuyan Zhao; Jie Zhao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-14       Impact factor: 4.342

5.  Local infiltration analgesia with additional intraarticular catheter provide better pain relief compared to single-shot local infiltration analgesia in TKA.

Authors:  Malin Meier; Sarah Sommer; Jochen Huth; Christian Benignus; Emmanuel Thienpont; Johannes Beckmann
Journal:  Arch Orthop Trauma Surg       Date:  2020-09-19       Impact factor: 3.067

Review 6.  Knee Osteoarthritis: A Primer.

Authors:  Michelle J Lespasio; Nicolas S Piuzzi; M Elaine Husni; George F Muschler; Aj Guarino; Michael A Mont
Journal:  Perm J       Date:  2017

Review 7.  Infection after total knee arthroplasty and its gold standard surgical treatment: Spacers used in two-stage revision arthroplasty.

Authors:  Junren Lu; Jing Han; Chi Zhang; Yi Yang; Zhenjun Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

8.  Periarticular injections with continuous perfusion of local anaesthetics provide better pain relief and better function compared to femoral and sciatic blocks after TKA: a randomized clinical trial.

Authors:  A Stathellis; W Fitz; C Schnurr; F X Koeck; M Gebauer; J Huth; G Bauer; J Beckmann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-13       Impact factor: 4.342

9.  The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee.

Authors:  Alberto Gobbi; Dnyanesh Lad; Georgios Karnatzikos
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-20       Impact factor: 4.342

10.  Thirty-day complications in rheumatoid patients following total knee arthroplasty.

Authors:  Julio J Jauregui; Bhaveen H Kapadia; Anant Dixit; Qais Naziri; David J Hip-Flores; Steven F Harwin; Michael A Mont
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.